» Articles » PMID: 23601660

Delivery of Reprogramming Factors into Fibroblasts for Generation of Non-genetic Induced Pluripotent Stem Cells Using a Cationic Bolaamphiphile As a Non-viral Vector

Overview
Journal Biomaterials
Date 2013 Apr 23
PMID 23601660
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Protein delivery allows a clinical effect to be directly realized without genetic modification of the host cells. We have developed a cationic bolaamphiphile as a non-viral vector for protein delivery application. The relatively low toxicity and efficient protein delivery by the cationic bolaamphiphile prompted us to test the system for the generation of induced pluripotent stem cells (iPSCs) as an alternative to the conventional vector-based genetic approach. Studies on the kinetics and cytotoxicity of the protein delivery system led us to use an optimized cationic bolaamphiphile-protein complex ratio of 7:1 (wt/wt) and a 3 h period of incubation with human fibroblasts, to ensure complete and non-toxic protein delivery of the reprogramming proteins. The reprogrammed cells were shown to exhibit the characteristics of embryonic stem cells, including expression of pluripotent markers, teratoma formation in SCID mice, and ability to be differentiated into a specific lineage, as exemplified by neuronal differentiation.

Citing Articles

Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells.

Lin Y, Ku C, Wuputra K, Liu C, Wu D, Satou M Int J Mol Sci. 2024; 25(10).

PMID: 38791215 PMC: 11120835. DOI: 10.3390/ijms25105177.


Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies.

Nath S, Menendez L, Friedrich Ben-Nun I Int J Mol Sci. 2023; 24(23).

PMID: 38069252 PMC: 10706975. DOI: 10.3390/ijms242316929.


RNA-Based Strategies for Cell Reprogramming toward Pluripotency.

Bailly A, Milhavet O, Lemaitre J Pharmaceutics. 2022; 14(2).

PMID: 35214051 PMC: 8876983. DOI: 10.3390/pharmaceutics14020317.


Osteogenesis Imperfecta: Current and Prospective Therapies.

Botor M, Fus-Kujawa A, Uroczynska M, Stepien K, Galicka A, Gawron K Biomolecules. 2021; 11(10).

PMID: 34680126 PMC: 8533546. DOI: 10.3390/biom11101493.


Intracellular Delivery of Proteins into Living Cells by Low-Molecular-Weight Polyethyleneimine.

Wu Y, Jiang L, Dong Z, Chen S, Yu X, Tang S Int J Nanomedicine. 2021; 16:4197-4208.

PMID: 34188469 PMC: 8232877. DOI: 10.2147/IJN.S315444.